DOST approves clinical trials for 'lagundi' as therapeutic supplement for COVID-19

DOST approves clinical trials for 'lagundi' as therapeutic supplement for COVID-19

Bibliographic Details
Published in:Manila Bulletin Vol. 571, no. 19 (19 Jul. 2020), 5
Main Author: Nazario, Dhel
Format: Article
Published: 2020
Subjects:
Lagundi > Therapeutic use
Clinical trials
Philippines. Department of Science and Technology. Philippine Council for Health Research and Development